Related Experiment Videos

Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking

H Chabriat1, S Pappata, L Ostergaard

  • 1Department of Neurology, CHU Lariboisière, Université Paris VII, France. chabriat@ccr.jussieu.fr

Stroke
|August 6, 2000
PubMed

Insights

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) patients show reduced white matter blood flow and reserve, especially in lesions. This hypoperfusion correlates with disease severity and may improve with vasodilation therapy.

Area of Science:

  • Neuroimaging
  • Cerebrovascular Diseases
  • White Matter Lesions

Background:

  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is characterized by white matter lesions due to arteriolar wall changes.
  • Chronic ischemia is suspected, but white matter perfusion and hemodynamic reserve patterns in CADASIL are not well understood.

Purpose of the Study:

  • To investigate white matter perfusion abnormalities and hemodynamic reserve in CADASIL patients.
  • To assess the impact of acetazolamide (ACZ) on cerebral blood flow (CBF) and blood volume (CBV) in CADASIL.

Main Methods:

  • MRI bolus tracking was used in 15 CADASIL patients and 10 controls.
  • Cerebral blood flow (CBF), blood volume (CBV), and mean transit time (MTT) were calculated before and after acetazolamide (ACZ) administration.
  • Perfusion parameters were analyzed in white matter hyperintensities and normal-appearing white matter.

Main Results:

  • CADASIL patients exhibited reduced white matter CBF and CBV in T2 hyperintensities, more pronounced in those with dementia.
  • Cortical CBF and CBV showed no significant change, though relative values decreased in the occipital cortex.
  • Acetazolamide (ACZ) increased CBF and CBV in both groups, but the response was blunted in white matter lesions of CADASIL patients.

Conclusions:

  • Areas of white matter hyperintensities in CADASIL demonstrate reduced basal perfusion and hemodynamic reserve.
  • This hypoperfusion is linked to clinical severity.
  • Pharmacological vasodilation with ACZ shows potential for improving cerebral perfusion in CADASIL.
Abstract

Related Concept Videos